This website uses technical, analytics and third party cookies. By continuing to browse, you accept our cookies.
Follow us on
AIFA has published the updated Transparency Lists of generic medicines together with the related reference prices, updated at 15 September 2021.
The aim of this new publication is to evaluate how access to medicines for the main chronic diseases is related to specific socio-economic factors
AIFA has published the updated weekly data concerning treatments with new second-generation direct acting antiviral agents (DAAs) for chronic hepatitis C, as collected by AIFA Monitoring registries.
The Italian Medicines Agency has published its eighth Pharmacovigilance Report on COVID-19 Vaccines.
Withdrawals and bans on use
Notices on shortages
Access to medicinal products
Safety of medicinal products
Quality and Inspections
Research and Clinical trials
Pricing and reimbursement
Consumption and pharmaceutical expenditure
Innovation and planning
Information and communication
Find here more detailed information and documents
Report a suspected adverse reaction online
FarmaciLine – Independent Pharmaceuticals Information Centre
Equivalent medicinal products
Requests for authorisation of conferences and meetings
National Observatory on Clinical Trials
Medicinal products authorised in 2020
GCP inspections in 2020
Clinical trials authorised in 2020
GVP inspections 2020
GMP inspections (Medicinal products) 2020
Orphan drugs authorised in 2019
10:30 - 20:00
Riunione Commissione Tecnico Scientifica (CTS)
10:00 - 13:00
OsMed: Atlante delle disuguaglianze sociali nell'uso dei farmaci per la cura delle principali malattie croniche
Riunione Comitato Prezzi e Rimborso (CPR)